Keywords: novartis, mrsa, drug, cubicin, launched, uk, swiss

Novartis' MRSA drug Cubicin launched in UK

Article | 24 September 2007

Print This

Swiss drug major Novartis has launched its new antibiotic Cubicin (daptomycin) in the UK for the treatment of both methicillin-sensitive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in